Prognosis value of residual disease monitoring by polymerase chain reaction in patients with CBFβ/MYH11-positive acute myeloblastic leukemia [3]

Blood

Volumn 89, Issue 6, 1997, Pages 2222-2223

  Costello, R ^a   Sainty, D ^a   Blaise, D ^a   Gastaut, J A ^a   Gabert, J ^a   Poirel, H ^a   Buzyn Veil, A ^a   Macintyre, E ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; AUTORADIOGRAPHY; BLOOD SAMPLING; BONE MARROW EXAMINATION; CLINICAL ARTICLE; HUMAN; LETTER; LEUKEMIA REMISSION; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0030968535     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)